Literature DB >> 17722963

Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients: a viewpoint by Helio Tedesco Silva Jr.

Helio Tedesco Silva1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17722963     DOI： 10.2165/00003495-200767130-00014

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  3 in total

1.  Immunosuppression: evolution in practice and trends, 1994-2004.

Authors:  H-U Meier-Kriesche; S Li; R W G Gruessner; J J Fung; R T Bustami; M L Barr; A B Leichtman
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

Review 2.  Aminoglycoside nephrotoxicity: do time and frequency of administration matter?

Authors:  D Beauchamp; G Labrecque
Journal:  Curr Opin Crit Care       Date:  2001-12       Impact factor: 3.687

3.  One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.

Authors:  H T Silva; H C Yang; M Abouljoud; P C Kuo; K Wisemandle; P Bhattacharya; S Dhadda; J Holman; W Fitzsimmons; M Roy First
Journal:  Am J Transplant       Date:  2007-01-11       Impact factor: 8.086
  3 in total
  3 in total

Review 1.  Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Authors:  Mary B Prendergast; Robert S Gaston
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

2.  Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.

Authors:  Jean-Baptiste Woillard; Brenda C M de Winter; Nassim Kamar; Pierre Marquet; Lionel Rostaing; Annick Rousseau
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.

Authors:  Khaled Benkali; Lionel Rostaing; Aurélie Premaud; Jean-Baptiste Woillard; Franck Saint-Marcoux; Saik Urien; Nassim Kamar; Pierre Marquet; Annick Rousseau
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.